OrbusNeich unveils device to prevent restenosis in DAPT patients

05/29/2013 | MedGadget.com

OrbusNeich has introduced its COMBO Dual Therapy Stent, designed to prevent the recurrence of stenosis, or narrowed blood vessels, in patients undergoing dual antiplatelet therapy. The sirolimus-eluting stent is covered with Anti-CD34 antibodies that absorb endothelial progenitor cells from passing blood to speed up the healing process.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA